Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

被引:158
|
作者
Berger, C
deMuret, A
Garaud, P
Chapet, S
Bourlier, P
ReynaudBougnoux, A
Dorval, E
deCalan, L
Huten, N
leFloch, O
Calais, G
机构
[1] HOP BRETONNEAU, CLIN ONCOL & RADIOTHERAPIE, TOURS, FRANCE
[2] HOP TROUSSEAU, ANAT PATHOL LAB, TOURS, FRANCE
[3] CHRU BRETONNEAU, LAB PATHOL CELLULAIRE, TOURS, FRANCE
[4] HOP TROUSSEAU, MALADIES APPAREIL DIGESTIF & NUTR, TOURS, FRANCE
[5] HOP TROUSSEAU, SERV CHIRURG DIGEST, TOURS, FRANCE
关键词
rectal carcinoma; preoperative radiotherapy; tumor downstaging; tumor sterilization; prognostic factors;
D O I
10.1016/S0360-3016(96)00577-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine predictive factors and prognostic value of tumor downstaging and tumor sterilization after preoperative RT for rectal cancer. Methods and Materials: Between 1977 and 1994, 167 patients with a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 local recurrences) underwent preoperative RT. Median dose was 44 Gy (5-73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Pathologic specimens have been reviewed by the same pathologist in order to specify the modified Astler Coller classification (MAC), and to quantify the residual tumor cell density (RTCD). Results: According to the MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%), and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the patients who received a dose greater than or equal to 44 Gy had respectively a 0-A and a B tumor, compared to 4 and 69% in those who received a dose <44 Gy (p = 0.04). Tumor differentiation and a longer interval before surgery were significantly associated with a more frequent downstaging, and preoperative staging correlated well to the postoperative pathological findings. According to the RTCD, 62 tumors (37%) showed no or only rare foci of residual tumor cells (Group 1); 62 (37%) showed an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3). No predictive factor of RTCD was statistically significant. In univariate analysis, postoperative staging was a significant prognostic factor, with corresponding 5-year overall survival rates in 0-A, B, and C stages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor. However, overall and disease-free survival rates for patients with complete pathologic response of 83% at 2 and 5 years suggested a better outcome in this subgroup of patients. Conclusion: The favorable influence of higher doses of preoperative RT on pathologic stage has been observed. Tumor differentiation, preoperative classification and time before surgery were the other predictive factors of tumor downstaging. However, there was no predictive factor of complete pathologic response. Even after preoperative RT, postoperative staging remained a prognostic factor. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [1] Prognostic value and predictive factors of tumor sterilization after preoperative radiotherapy for rectal cancer
    Berger, C
    deMuret, A
    Chapet, S
    Calais, G
    ReynaudBougnoux, A
    Dorval, E
    deCalan, L
    Huten, N
    LeFloch, O
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 707 - 707
  • [2] Tumor downstaging is prognostic following treatment for rectal cancer
    Nature Clinical Practice Oncology, 2007, 4 (3): : 145 - 145
  • [3] TUMOR DOWNSTAGING AND SPHINCTER PRESERVATION WITH PREOPERATIVE CHEMORADIOTHERAPY FOR RECTAL CANCER
    Ronzoni, M.
    Vitali, G.
    Reni, M.
    Di Palo, S.
    Staudacher, C.
    Villa, E.
    ANNALS OF ONCOLOGY, 2004, 15 : 59 - 59
  • [4] Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer
    Suzuki, T
    Sadahiro, S
    Fukasawa, M
    Ishikawa, K
    Kamijo, A
    Yasuda, S
    Makuuchi, H
    Ohizumi, Y
    Murayama, C
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (12) : 740 - 746
  • [5] Prognostic factors for tumor histological response to preoperative chemoradiation in rectal cancer
    Kundel, Y.
    Brenner, R.
    Abramovich, A.
    Purim, O.
    Peled, N.
    Idelevich, E.
    Nisenbaum, B.
    Fenig, E.
    Sulkes, A.
    Brenner, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy
    Zlobec, I
    Steele, R
    Compton, CC
    CANCER, 2005, 104 (11) : 2517 - 2521
  • [7] Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer
    Treder, Maxi
    Vogelsang, Rasmus Peuliche
    Janssen, Stefan
    Schild, Steven E.
    Hollanders, Niels Henrik
    Rades, Dirk
    IN VIVO, 2018, 32 (06): : 1481 - 1484
  • [8] Predictors of tumor response and downstaging in patients treated with preoperative chemoradiation for rectal cancer
    Das, P.
    Skibber, J. M.
    Rodriguez-Bigas, M. A.
    Feig, B. W.
    Chang, G. J.
    Wolff, R. A.
    Eng, C.
    Janjan, N. A.
    Krishnan, S.
    Crane, C. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S167 - S168
  • [9] Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer
    Adell, G
    Zhang, H
    Jansson, A
    Sun, XF
    Stål, O
    Nordenskjöld, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (03): : 659 - 663
  • [10] Predictive factors and prognostic significance of tumor regression grade in rectal cancer.
    Ogundimu, Oluwabunmi
    Ramjeesingh, Ravi
    Ren, Kevin
    Qu, Melody Xuan Lu
    Hurlbut, David
    Biagi, James Joseph
    Mahmud, Aamer
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)